JAMA 1984-05-04

Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan.

L S Goodman, M M Wintrobe, W Dameshek, M J Goodman, A Gilman, M T McLennan

Index: JAMA 251(17) , 2255-61, (1984)

Full Text: HTML

Structure	Name/CAS No.	Molecular Formula	Articles
	Trichlormethine (hydrochloride) CAS:817-09-4	C₆H₁₃Cl₄N

Identification of the nitrogen-based blister agents bis(2-ch...
2000-12-01
[J. Mass Spectrom. 35(12) , 1460-9, (2000)]

Ameliorative effect of DRDE 07 and its analogues on the syst...
2010-09-01
[Hum. Exp. Toxicol. 29(9) , 747-55, (2010)]

Carcinogenicity of trichloromethine hydrochloride (TS-160 Sp...
1981-01-01
[Neoplasma 28(5) , 565-74, (1981)]

Treatment of advanced Hodgkin's disease with modified MOPP r...
1989-01-01
[Neoplasma 36(6) , 709-18, (1989)]

The effects of radiation and alkylating agents on chromatin ...
1991-02-01
[Gen. Physiol. Biophys. 10(1) , 41-8, (1991)]